Table 5.

Rankings of preferences of COVID-19 vaccine type among vaccinated respondents, ranked by frequency of preference given

Preference of vaccine type	Likelihood/rank of getting vaccinated
	Extremely likely (n = 256)	Somewhat likely (n = 223)	Combined (n = 479)
Not enough knowledge and information to make a decision	1st (58.2%)	1st (65.9%)	1st (61.8%)
The vaccine contains the partial genetic code (mRNA) of the virus (Moderna and Pfizer/BioNTech)	2nd (15.6%)	2nd (14.3%)	2nd (15.0%)
The vaccine contains a modified version of the virus (Oxford University/AstraZeneca)	3rd (12.9%)	4th (7.2%)	3rd (10.2%)
The vaccine contains the inactivated virus. (SinoVac)	4th (8.2%)	3rd (9.0%)	4th (8.6%)
The vaccine contains fragments of specific proteins from the virus (Novavax)	5th (5.0%)	5th (3.6%)	5th (4.4%)